Transcriptional profiles of Trichophyton rubrum in response to itraconazole

Medical Mycology

Volumn 47, Issue 3, 2009, Pages 237-247

  Diao, Youjiang ^a,b   Zhao, Rong ^b,c   Deng, Xuming ^a   Leng, Wenchuan ^b,c   Peng, Junping ^b,c   Jin, Qi ^b,c  

^a JILIN UNIVERSITY   (China)

^b CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c INSTITUTE OF PATHOGEN BIOLOGY   (China)

Author keywords

Dermatophyte; Efflux pump; Mechanism of action; Microarray; Trichophyton rubrum

Indexed keywords

1,3 BETA GLUCAN SYNTHASE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ASPARTATE AMMONIA LIGASE; BIOTIN SYNTHASE; CELL MEMBRANE PROTEIN; CHITINASE; CHLORIDE PEROXIDASE; COPPER ZINC SUPEROXIDE DISMUTASE; CYTOCHROME C OXIDASE; ERGOSTEROL; FORMATE DEHYDROGENASE; GLUTAMATE DECARBOXYLASE; GLUTATHIONE TRANSFERASE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HEAT SHOCK PROTEIN; ISOCITRATE LYASE; ISOVALERYL COENZYME A DEHYDROGENASE; ITRACONAZOLE; KETOL ACID REDUCTOISOMERASE; LANOSTEROL SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; MONOCARBOXYLATE TRANSPORTER; MYOINOSITOL 1 PHOSPHATE SYNTHASE; PHOSPHOSERINE; PYRIDOXINE; SODIUM CALCIUM EXCHANGE PROTEIN; STEROL 14ALPHA DEMETHYLASE; UBIQUINONE; ANTIFUNGAL AGENT;

ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CELL TRANSPORT; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; DOWN REGULATION; EFFUSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE OVEREXPRESSION; HOMEOSTASIS; HYBRIDIZATION; ION TRANSPORT; LIPID METABOLISM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN METABOLISM; PROTEIN MICROARRAY; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TRICHOPHYTON RUBRUM; UNINDEXED SEQUENCE; UPREGULATION; DNA MICROARRAY; DRUG EFFECT; GENETICS; PHYSIOLOGICAL STRESS; TRICHOPHYTON;

ARTHRODERMATACEAE; TRICHOPHYTON RUBRUM;

ANTIFUNGAL AGENTS; GENE EXPRESSION PROFILING; ITRACONAZOLE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; STRESS, PHYSIOLOGICAL; TRICHOPHYTON;

EID: 66449110547     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.1080/13693780802227308     Document Type: Article

References (51)

1. Weitzman I, Summerbell RC. The dermatophytes. Clin Microbiol Rev 1995; 8: 240-259.
2. Gong JQ, Liu XQ, Xu HB, et al. Deep dermatophytosis caused by Trichophyton rubrum: Report of two cases. Mycoses 2007; 50 102-108.
3. Tsang P, Hopkins T, Jimenez-Lucho V. Deep dermatophytosis caused by Trichophyton rubrum in a patient with AIDS. J Am Acad Dermatol 1996; 34: 1090-1091.
4. Lestringant GG, Lindley SK, Hillsdon-Smith J, et al. Deep dermatophytosis to Trichophyton rubrum and T. verrucosum in an immunosuppressed patient. Int J Dermatol 1986; 27: 707-709.
5. Marques SA, Robles AM, Tortorano AM, et al. Mycoses associated with AIDS in the Third World. Med Mycol 2000; 38: 269-279.
6. Kemna ME, Elewski BE. A U.S. epidemiologic survey of superficial fungal diseases. J Am Acad Dermatol 1996; 35: 539-542.
7. Del Palacio A, Garau M, Gonzalez-Escalada A, et al. Trends in the treatment of dermatophytosis. In: Kushwaha RKS, Guarro J (eds)., Biology of Dermatophytes and Other Keratinophilic Fungi. Bilbao, País Vasco, Spain: Revista Iberoamericana de Micología. 2000:148-158.
8. Hay RJ, Clayton YM, Moore MK, et al. Itraconazole in the management of chronic dermatophytoses. J Am Acad Dermatol 1990; 23: 561-564.
9. Nagino K, Shimohira H, Ogawa M, et al. Comparison of the therapeutic efficacy of oral doses of fluconazole and itraconazole in a guinea pig model of dermatophytosis. J Infect Chemother 2000; 6 41-44.
10. Roberts DT. Oral terbinafine (Lamisil) in the treatment of fungal infections of the skin and nails. Dermatology 1997; 194: 37-39.
11. Saul A, Bonifaz A, Arias I. Itraconazole in the treatment of superficial mycoses: An open trial of 40 cases. Rev Infect Dis 1987; 9: S100-S103.
12. Lupetti A, Danesi R, Campa M, et al. Molecular basis of resistance to azole antifungals. Trends Mol Med 2002; 8: 76-81.
13. Agarwal AK, Rogers PD, Baerson SR, et al. Genome-wide expression profiling of the response to polyene, pyrimidine, azole, and echinocandin antifungal agents in Saccharomyces cerevisiae. J Biol Chem 2003; 278: 34998-5015.
14. Brown PO, Botstein D. Exploring the new world of the genome with DNA microarrays. Nature Genetics 1999; 21: 33-37.
15. Bammert GF, Fostel JM. Genome-wide expression patterns in Saccharomyces cerevisiae: Comparison of drug treatments and genetic alterations affecting biosynthesis of ergosterol. Antimicrob Agents Chemother 2000; 44: 1255-1265.
16. Liu TT, Lee REB, Barker KS, et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 2005; 49: 2226-2236.
17. De Hoog GS, Guarro J, Gené J (eds). Atlas of Clinical Fungi, 2nd edn. Centraalbureau voor Schimmelcultures, Utrecht, The Netherlands, and University Rovirai Virgili, Reus, Spain. 2000.
18. Larone DH (ed.). Medically Important Fungi: A Guide to Identification 4th edn. Washington, DC:AMerican Society for Microbiology, 2002.
19. Jackson CJ, Barton RC, Evans EGV. Species identification and strain differentiation of dermatophyte fungi by analysis of ribosomal-DNA intergenic spacer regions. J Clin Microbiol 1999; 37: 93-936.
20. Meevootisom V, Niederpruem DJ. Control of exocellular proteases in dermatophytes and especially Trichophyton rubrum. Sabouraudia 1979; 17: 91-106.
21. Wang L, Ma L, Leng W, et al. Analysis of the dermatophyte Trichophyton rubrum expressed sequence tags. BMC Genomics 2006; 7: 255.
22. Peng J, Zhang X, Yang J, et al. The use of comparative genomic hybridization to characterize genome dynamics and diversity among the serotypes of Shigella. BMC Genomics 2006; 7: 218.
23. Diehl F, Grahlmann S, Beier M, et al. Manufacturing DNA-microarrays of high spot homogeneity and reduced background signal. Nucl Acids Res 2001; 29: E38.
24. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, PA, 2002.
25. Fernandez-Torres B, Cabanes FJ, Carrillo-Munoz AJ, et al. Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002; 40: 3999-4003.
26. Cleveland WS. Robust locally weighted regression and smoothing scatterplots. J Am Stat Assoc 1979; 74: 829-836.
27. Saeed AI, Sharov V, White J, et al. TM4: A free, open-source system for microarray data management and analysis. Biotechniques 2003; 34: 374-378.
28. Barry AL, Pfaller MA, Brown SD, et al. Quality control limits of broth microdilution susceptibility tests of ten antifungal agents. J Clin Microbiol 2000; 38: 3457-3459.
29. Yang J, Chen L, Wang L, et al. TrED: The Trichophyton rubrum expression database. BMC Genomics 2007; 8: 250.
30. Ghannoum MA, Rice LB. Antifungal agents: Mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12: 501-517.
31. Liu TT, Lee RE, Barker KS, et al. Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 2005; 49: 2226-2236.
32. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
33. White TC. Increased mRNA levels of ERG16, CDR, and MDR1 correlate with increases on azole resistance in Candida albicans isolates from a patient infected with human immunodeficiency virus. Antimicrob Agents Chemother 1997; 42: 1488-1494.
34. Swain E, Baudry K, Stukey J, et al. Sterol-dependent regulation of sphingolipid metabolism in Saccharomyces cerevisiae. J Biol Chem 2002; 277: 26177-26184.
35. Majumder AL, Johnson MD, Henry SA. 1L-myo-inositol-1-phosphate synthase. Biochem Biophys Acta 1997; 1348: 245-256.
36. Arganoff BW, Fisher SK. Phosphoinositides and their stimulated breakdown. In: Reitz AB (ed.). Inositol Phosphates and Derivatives Washington, DC: American Chemical Society, 1991: 20-32.
37. Exton JH. Mechanisms involved in calcium-mobilizing agonist responses. Adv Cyclic Nucl Prot Phosphor Res 1986; 20: 211-262.
38. Potter BVL, Lampe D. Chemistry of inositol lipid mediated cellular signaling. Angew Chem Int Ed Engl 1995; 34: 1933-1972.
39. Mao C, Obeid LM. Yeast sphingosine-1-phosphate phosphatases: Assay, expression, deletion, purification and cellular localization by GFP tagging. Meth Enzymol 2000; 311: 223-232.
40. De Backer MD, Ilyina T, Ma X, et al. Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob Agents Chemother 2001; 45: 1660-1670.
41. Hwang CS, Rhie GE, Oh JH, et al. Copper- and zinc-containing superoxide dismutase (Cu/ZnSOD) is required for the protection of Candida albicans against oxidative stresses and the expression of its full virulence. Microbiology 2002; 148: 3705-3713.
42. Culotta VC, Joh HD, Lin SJ, et al. A physiological role for Saccharomyces cerevisiae copper/zinc superoxide dismutase in copper buffering. J Biol Chem 1995; 270: 29991-29997.
43. Hwang CS, Baek YU, Yim HS, et al. Protective roles of mitochondrial manganese-containing superoxide dismutase against various stresses in Candida albicans. Yeast 2003; 20: 929-941.
44. Veal EA, Toone WM, Jones N, et al. Distinct roles for glutathione S-transferases in the oxidative stress response in Schizosaccharomyces pombe. J Biol Chem 2002; 277: 35523-35531.
45. Rogers PD, Barker KS. Genome-wide expression profile analysis reveals coordinately regulated genes associated with stepwise acquisition of azole resistance in Candida albicans clinical isolates. Antimicr Agents Chemother 2003; 47: 1220-1227.
46. White TC, Marr KA, Bowden RA. Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. Clin Microbiol Rev 1998; 11: 382-402.
47. Jung US, Levin DE. Genome-wide analysis of gene expression regulated by the yeast cell wall integrity-signalling pathway. Mol Microbiol 1999; 34: 1049-1057.
48. Rogers B, Decottignies A, Kolaczkowski M, et al. The pleitropic drug ABC transporters from Saccharomyce scerevisiae. J Mol Microbiol Biotechnol 2001; 3: 207-14.
49. Balzi E, Goffeau A. Yeast multidrug resistance: The PDR network. J Bioenerg Biomembr 1995; 27: 71-76.
50. Gupta AK, Sauder DN, Shear NH. Antifungal agents: An overview. Part II. J Am Acad Dermatol 1994; 30: 911-933.
51. Edlind T, Smith L, Henry K, et al. Antifungal activity in Saccharomyces cerevisiae is modulated by calcium signaling. Mol Microbiol 2002; 46: 257-268.